Humana(HUM)

Search documents
Humana(HUM) - 2023 Q2 - Earnings Call Transcript
2023-08-02 17:05
Humana Inc. (NYSE:HUM) Q2 2023 Earnings Conference Call August 2, 2023 9:00 AM ET Company Participants Lisa Stoner - VP, IR Bruce Broussard - President and CEO Susan Diamond - CFO Conference Call Participants Stephen Baxter - Wells Fargo A.J. Rice - Credit Suisse Justin Lake - Wolfe Research Nathan Rich - Goldman Sachs Scott Fidel - Stephens Steve Valiquette - Barclays Michael Ha - Morgan Stanley Gary Taylor - Cowen Joshua Raskin - Nephron Research David Windley - Jefferies Kevin Fischbeck - Bank of America ...
Humana(HUM) - 2023 Q2 - Quarterly Report
2023-08-01 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-5975 HUMANA INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or o ...
Humana(HUM) - 2023 Q1 - Earnings Call Transcript
2023-04-26 17:25
Humana Inc. (NYSE:HUM) Q1 2023 Earnings Conference Call April 26, 2023 9:00 AM ET Company Participants Lisa Stoner - Vice President of Investor Relations Bruce Broussard - President and Chief Executive Officer Susan Diamond - Chief Financial Officer Conference Call Participants Gary Taylor - Cowen David Windley - Jefferies Stephen Baxter - Wells Fargo Justin Lake - Wolfe Research Lance Wilkes - Bernstein Nate Rich - Goldman Sachs Joshua Raskin - Nephron Research Scott Fidel - Stephens A.J. Rice - Credit Sui ...
Humana(HUM) - 2023 Q1 - Quarterly Report
2023-04-25 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-5975 HUMANA INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or ...
Humana(HUM) - 2022 Q4 - Annual Report
2023-02-15 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 1-5975 HUMANA INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation of organization) ...
Humana(HUM) - 2022 Q4 - Earnings Call Transcript
2023-02-01 18:46
Humana Inc. (NYSE:HUM) Q4 2022 Earnings Conference Call February 1, 2023 9:00 AM ET Company Participants Lisa Stoner – Vice President-Investor Relations Bruce Broussard – President and Chief Executive Officer Susan Diamond – Chief Financial Officer Conference Call Participants Josh Raskin – Nephron Research A.J. Rice – Credit Suisse Justin Lake – Wolfe Research Kevin Fischbeck – Bank of America Stephen Baxter – Wells Fargo Scott Fidel – Stephens Gary Taylor – Cowen Nathan Rich – Goldman Sachs Lisa Gill – JP ...
Humana(HUM) - 2022 Q3 - Earnings Call Transcript
2022-11-02 15:42
Humana Inc. (NYSE:HUM) Q3 2022 Earnings Conference Call November 2, 2022 9:00 AM ET Company Participants Lisa Stoner – Vice President-Investor Relations Bruce Broussard – President and Chief Executive Officer Susan Diamond – Chief Financial Officer Conference Call Participants Stephen Baxter – Wells Fargo Kevin Fischbeck – Bank of America Justin Lake – Wolfe Research Nathan Rich – Goldman Sachs Gary Taylor – Cowen Scott Fidel – Stephens George Hill – Deutsche Bank Josh Raskin – Nephron Research A.J. Rice – ...
Humana(HUM) - 2022 Q3 - Quarterly Report
2022-11-01 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-5975 HUMANA INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation ...
Humana(HUM) - 2022 Q2 - Earnings Call Transcript
2022-07-27 18:37
Humana Inc. (NYSE:HUM) Q2 2022 Earnings Conference Call July 27, 2022 9:00 AM ET Company Participants Lisa Stoner - Vice President, Investor Relations Bruce Broussard - President and Chief Executive Officer Susan Diamond - Chief Financial Officer Joe Ventura - Chief Legal Officer Conference Call Participants Justin Lake - Wolfe Research Matt Borsch - BMO Capital Markets Kevin Fischbeck - Bank of America A.J. Rice - Credit Suisse Nathan Rich - Goldman Sachs Joshua Raskin - Nephron Research Ricky Goldwasser - ...
Humana(HUM) - 2022 Q2 - Quarterly Report
2022-07-26 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-5975 HUMANA INC. (Exact name of registrant as specified in its charter) Delaware 61-0647538 (State or other jurisdiction o ...